Filtering by:
Cancer UpdatesFDA Approves First Targeted Therapy for Bladder Cancer
The US Food and Drug Administration (FDA) has approved Balversa (erdafitinib) as the first targeted therapy for bladder cancer.
FDA Warns of Cancer Risk in a Type of Uterine Fibroid Surgery
The US Food and Drug Administration (FDA) is warning women and doctors about the risks of a certain technique used in surgery for uterine fibroids.
ACS Report: More Effort Needed to Reduce Cancer Risk in the US
A new report from the American Cancer Society says cancer death rates could fall more quickly – if more people had the resources they needed to adopt lifestyle behaviors that reduce risk.
Even Light Levels of Physical Activity Provide Benefits
A new study from researchers at the American Cancer Society finds that even light levels of physical activity are healthier than just sitting.
FDA Approves Tecentriq (Atezolizumab) for Small Cell Lung Cancer
The US Food and Drug Administration (FDA) has approved the immunotherapy drug Tecentriq (atezolizumab) for the treatment of small cell lung cancer (SCLC).
Breast Cancer Patients Make Recommendations to Address High Health Care Costs
Breast cancer patients, especially if they have lymphedema, face an especially high cost of health care according to authors of a paper published March 6, 2019 in Cancer, a peer-reviewed medical journal of the American Cancer Society.
It’s Never Too Late to Get More Exercise
A new study shows once again, that getting some exercise will pay healthy dividends, even if you start making the effort later in life.
FDA Approves Immunotherapy for Breast Cancer
The US Food and Drug Administration today approved the first immunotherapy treatment for breast cancer. It approved a combination of Tecentriq (atezolizumab) and Abraxane (nab-paclitaxel) for people with advanced triple negative breast cancer.
